Medicrea reported a net profit loss of 1.2 percent in 2012. However, Medicrea, a company focused on orthopedic spine implants, reported an 8.5 percent sales increase in the United States. The company plans to develop sales activity in the U.S. with its PASS LP product and obtain FDA approval for its K-Jaws technology in 2013.
The group has also been in negotiation with potential American partners for its Granvia-C cervical disc.
More Articles on Spine Devices:
K2M Launches VENADO Biologic Bone Graft System
Amedica Valeo Interbody Fusion Device Hits 10k Implantations
X-spine Receives FDA Clearance for Silex Sacroiliac Joint Fusion Device
The group has also been in negotiation with potential American partners for its Granvia-C cervical disc.
More Articles on Spine Devices:
K2M Launches VENADO Biologic Bone Graft System
Amedica Valeo Interbody Fusion Device Hits 10k Implantations
X-spine Receives FDA Clearance for Silex Sacroiliac Joint Fusion Device